Zymeworks ZYME Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value at other companies
Other financials
Where this comes from
Reported directly by Zymeworks in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue.
The official record: Zymeworks’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zymeworks's share based compensation arrangement by share based payment award options exercises in period total intrinsic value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zymeworks's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Zymeworks (ZYME) reported share based compensation arrangement by share based payment award options exercises in period total intrinsic value of $3.54M in Q4 2025.
- How has Zymeworks's share based compensation arrangement by share based payment award options exercises in period total intrinsic value changed year-over-year?
- Zymeworks's share based compensation arrangement by share based payment award options exercises in period total intrinsic value increased by 531.2% year-over-year, from $560.5K to $3.54M.
- What is the long-term trend for Zymeworks's share based compensation arrangement by share based payment award options exercises in period total intrinsic value?
- Over 2 years (2023 to 2025), Zymeworks's share based compensation arrangement by share based payment award options exercises in period total intrinsic value has grown at a 332.1% compound annual growth rate (CAGR), from $758K to $14.15M.
- What does share based compensation arrangement by share based payment award options exercises in period total intrinsic value mean?
- The difference between the market price of the company's common stock and the exercise price of the options at the time of exercise. This metric represents the realized economic benefit captured by employees upon exercising their vested stock options. It provides insight into the alignment between employee incentives and shareholder value creation.